Hansa Biopharma AB (publ)

HNSA.ST·Stockholm·Healthcare
Compare
40.38+0.64 (+1.61%)today
As of Nov 5, 9:28 AM CET · May be delayed up to 15 min · SEK

Prices may be delayed up to 15 min. Not investment advice. News volume: articles in the 4Search index each day.

Key statistics

Previous close39.74
Open39.98
Day range39.9840.84
52-week range23.5248.22
Off day high−1.13%
Off 52-week high−16.26%
Volume106.15K
Avg. volume (3M)568.53K
Market cap4.03B
EPS (TTM)-7.64
Forward P/E-5.48
P/E ratio (TTM)—
Dividend yield—
Beta (5Y)1.66
Shares outstanding99.73M
Short interest—
Earnings dateNov 11, 2026
Analyst target73.00
Profit margin0.00%

Against its peers

Compare in full ›
HNSA.ST ARGX ABCL 2142.HK GENO.ST ROIV
Market cap 4.03B 58.57B 3.98B 9.31B 1.46B 27.61B
P/E (TTM) — 32.3 — 12.5 72.3 —
Forward P/E -5.5 28.0 -16.1 12.0 46.2 -27.5
Price/book -7.9 173.0 4.2 2.7 4.8 6.5
Dividend yield — — — — — —
1-year change +31.27% +8.26% +159.70% −20.03% +0.24% +78.15%
Today +1.61% +3.36% +0.82% +5.62% +2.60% +6.08%

The closest companies by business and industry (Biotechnology). Prices may be delayed up to 15 min.

Latest news

All HNSA.ST news ›

From the 4Search news index, newest first.

In the news

1mentions in 30 days
1with it in the headline
Negativesentiment

Finance and business coverage in the 4SEARCH.business news index: articles that name it in the headline, or in the text beside its ticker. Sentiment is the index's own reading of the latest 1 articles, not a forecast.

Market data is provided for information only and comes from free public sources. Prices may be delayed up to 15 minutes; data may be incomplete or inaccurate. Nothing on this page is investment advice or a recommendation to buy or sell any security. News and coverage analytics are drawn from the 4SEARCH.business index. Terms of use. How to use Finance